Literature DB >> 24911412

Proteotoxicity is not the reason for the dependence of cancer cells on the major chaperone Hsp70.

Teresa A Colvin1, Vladimir L Gabai2, Michael Y Sherman2.   

Abstract

Several years ago a hypothesis was proposed that the survival of cancer cells depend on elevated expression of molecular chaperones because these cells are prone to proteotoxic stress. A critical prediction of this hypothesis is that depletion of chaperones in cancer cells should lead to proteotoxicity. Here, using the major chaperone Hsp70 as example, we demonstrate that its depletion does not trigger proteotoxic stress, thus refuting the model. Accordingly, other functions of chaperones, e.g., their role in cell signaling, might define the requirements for chaperones in cancer cells, which is critical for rational targeting Hsp70 in cancer treatment.

Entities:  

Keywords:  Hsp70; chaperone; non-oncogene addiction; proteotoxic stress; rational drug targeting

Mesh:

Substances:

Year:  2014        PMID: 24911412      PMCID: PMC4111684          DOI: 10.4161/cc.29296

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR.

Authors:  Vladimir L Gabai; Le Meng; Geunwon Kim; Teresa A Mills; Ivor J Benjamin; Michael Y Sherman
Journal:  Mol Cell Biol       Date:  2012-01-03       Impact factor: 4.272

2.  The function of HSP72 in suppression of c-Jun N-terminal kinase activation can be dissociated from its role in prevention of protein damage.

Authors:  J A Yaglom; V L Gabai; A B Meriin; D D Mosser; M Y Sherman
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

3.  High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways.

Authors:  Julia A Yaglom; Vladimir L Gabai; Michael Y Sherman
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

4.  Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.

Authors:  J-N Min; L Huang; D B Zimonjic; D Moskophidis; N F Mivechi
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

5.  Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis.

Authors:  Caixia Xi; Yanzhong Hu; Phillip Buckhaults; Demetrius Moskophidis; Nahid F Mivechi
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

Review 6.  Heat shock proteins in cancer: chaperones of tumorigenesis.

Authors:  Stuart K Calderwood; Md Abdul Khaleque; Douglas B Sawyer; Daniel R Ciocca
Journal:  Trends Biochem Sci       Date:  2006-02-17       Impact factor: 13.807

7.  Non-oncogene addiction and the stress phenotype of cancer cells.

Authors:  Nicole L Solimini; Ji Luo; Stephen J Elledge
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

8.  Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells.

Authors:  Vladimir L Gabai; Julia A Yaglom; Todd Waldman; Michael Y Sherman
Journal:  Mol Cell Biol       Date:  2008-11-10       Impact factor: 4.272

9.  Identification of aneuploidy-tolerating mutations.

Authors:  Eduardo M Torres; Noah Dephoure; Amudha Panneerselvam; Cheryl M Tucker; Charles A Whittaker; Steven P Gygi; Maitreya J Dunham; Angelika Amon
Journal:  Cell       Date:  2010-09-16       Impact factor: 41.582

10.  Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Authors:  Chengkai Dai; Luke Whitesell; Arlin B Rogers; Susan Lindquist
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

View more
  4 in total

Review 1.  Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease.

Authors:  Jonathan A Kirk; Joseph Y Cheung; Arthur M Feldman
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456

2.  Cytoplasmic proteotoxicity regulates HRI-dependent phosphorylation of eIF2α via the Hsp70-Bag3 module.

Authors:  Shivani Patel; Santosh Kumar; Simone Baldan; Arkadi Hesin; Julia Yaglom; Michael Y Sherman
Journal:  iScience       Date:  2022-04-22

Review 3.  Hsp70 in cancer: back to the future.

Authors:  M Y Sherman; V L Gabai
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

Review 4.  HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy.

Authors:  Alexander E Kabakov; Vladimir L Gabai
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.